Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN

Hiromi Hirama, Mikio Sugimoto, Nobuyuki Miyatake, Takuma Kato, Lionne D.F. Venderbos, Sebastiaan Remmers, Kenichiro Shiga, Akira Yokomizo, Koji Mitsuzuka, Ryuji Matsumoto, Takahiro Osawa, Takashige Abe, Hiroshi Sasaki, Shin Egawa, Iku Ninomiya, Katsuyoshi Hashine, Monique J. Roobol, Yoshiyuki Kakehi

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


Purpose: To evaluate the health-related quality of life (HRQoL) of Japanese men on active surveillance (AS) in the Prostate cancer Research International Active Surveillance study in Japan (PRIAS-JAPAN). Methods: Participants were included in the PRIAS-JAPAN HRQoL study between January 2010 and March 2016. Their general HRQoL was assessed using a validated Japanese version of the Short-Form 8 Health Survey (SF-8) at enrolment and annually thereafter until discontinuation of AS. The SF-8 mental component summary (MCS) and physical component summary (PCS) of men on AS were compared with scores of the general population (norm-based score [NBS]: 50) and MCS and PCS scores for men following AS were analysed over time. We tested whether MCS and PCS scores over time explained discontinuation of AS. Results: Five hundred and twenty-five patients enrolled, and the median age at baseline was 68 years. At enrolment and after 1-, 2-, and 3-year follow-ups, the PCS and MCS scores were significantly higher than the NBS of the general Japanese population except for the median PCS at 3 years. We found that age at diagnosis and time on AS negatively affected the PCS score of men on AS, while every additional year on AS led to a 0.27 point increase in MCS scores. Neither PCS nor MCS were predictors for discontinuation of AS. Conclusion: Japanese men following an AS strategy for 3 years reported better HRQoL compared with the general population, indicating that monitoring Japanese low-risk prostate cancer patients can be an effective treatment strategy. Study registration: Clinical trial registry—UMIN (University Hospital Medical Information Network); UMIN000002874 (2009/12/11)

Original languageEnglish
Pages (from-to)2491-2497
Number of pages7
JournalWorld Journal of Urology
Issue number7
Publication statusPublished - 2021 Jul


  • Active surveillance
  • HRQoL
  • Japanese cohort
  • Low-risk prostate cancer
  • Patient‐reported outcome measurement

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN'. Together they form a unique fingerprint.

Cite this